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Abstract
Osteoarthritis (OA) is a prevalent, disabling disorder of the joints that affects a large population worldwide and for
which there is no definitive cure. This review provides critical insights into the basic knowledge on OA that may
lead to innovative end efficient new therapeutic regimens. While degradation of the articular cartilage is the
hallmark of OA, with altered interactions between chondrocytes and compounds of the extracellular matrix, the
subchondral bone has been also described as a key component of the disease, involving specific pathomechanisms
controlling its initiation and progression. The identification of such events (and thus of possible targets for therapy)
has been made possible by the availability of a number of animal models that aim at reproducing the human
pathology, in particular large models of high tibial osteotomy (HTO). From a therapeutic point of view, mesenchymal
stem cells (MSCs) represent a promising option for the treatment of OA and may be used concomitantly with
functional substitutes integrating scaffolds and drugs/growth factors in tissue engineering setups. Altogether, these
advances in the fundamental and experimental knowledge on OA may allow for the generation of improved, adapted
therapeutic regimens to treat human OA.
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Introduction
Osteoarthritis (OA) is a systemic, chronic joint disorder
classified into primary and secondary OA depending
on its etiology, characterized by the progressive break-
down of the articular cartilage (the end point of OA)
along with changes in the subchondral bone, synovium
(synovial inflammation), meniscus, tendons/ligaments,
and muscles (Fig. 1) (Loeser et al. 2012). OA is a multi-
factorial disorder that can be divided in non-genetic
(age, gender, obesity, mechanical stress, inactive life-
style, joint trauma, patient occupational activities) and
genetic (altered gene expression patterns of the cartil-
age and subchondral bone) factors. It can affect any
joint of the body but most significantly weightbearing
joints of lower extremities and the hand, causing pain
and impaired functionality in the adult population.
OA is a common condition limiting the quality of life
of patients, representing a social, economic burden
(Bijlsma et al. 2011). Its prevalence increases with aging
and obesity. Knee OA affects over 70 million Europeans,
and the direct costs exceed 2 billion euros. The disease
progression is commonly slow but ultimately leads to
joint malfunction as the cartilage has a poor regeneration
capability. According to World Health Organization
(WHO) Global Burden of Disease Study 2010, hip and
knee OA is the 11th leading cause of disability.
Traditional treatments, apart from exercise and weight
loss, include non-steroidal anti-inflammatory drugs
(NSAIDs), supplements (glucosamine, chondroitin), vis-
cosupplementation, arthroscopic lavage and debridement,
combined non-pharmacological and pharmacological mo-
dalities, and replacement surgery as a sustainable alterna-
tive in restricted situations. Still, none of these procedures
proved successful so far to fully reverse the OA phenotype
in patients, mostly because the pathogenesis of the disease
is still poorly understood.
On May 7th, 2016, clinicians and basic scientists from
Europe, North America, and Asia met on the occasion
of an Instructional Course Lecture (ICL16: Basic sci-
ence of osteoarthritis) at the 17th European Society of
Sports Traumatology, Knee Surgery & Arthroscopy
(ESSKA) Congress in Barcelona, Spain to explore the
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current knowledge of OA. The purpose of the present
contribution is to highlight new, critical aspects of clin-
ically relevant, scientific and translational OA research
based on individual presentations from orthopaedic
surgeons, cell and molecular biologists and biochem-
ists, biomaterial scientists and engineers (Table 1) that
may help define new pathways underlying OA patho-
genesis and subsequently to identify novel, potential
targets for OA therapy.
The bone in OA
The chronological events controlling the pathology of
OA are still debated but recent developments empha-
sized an early pathophysiological role of the subchon-
dral bone. The subchondral bone, located immediately
below the layer of calcified cartilage, forms the osteo-
chondral unit together with the articular cartilage. The
basophilic line on histological sections separating the
hyaline cartilage from the underlying calcified cartilage
is the tidemark while the border that separates the cal-
cified cartilage from the subchondral bone plate is the
cement line. Two parts constitute the subchondral
bone. The subchondral bone plate is composed of a
cortical bone plate and cancellous bone, which join to-
gether to enclose narrow intervening spaces. The highly
mineralized cortical plate is made of osteon units con-
taining a central Haversian canal with nerves and capil-
laries. Osteon units communicate with each other by
Volkmann canals. The trabecular bone modelling medul-
lar cavities instead have a level of mineralization of only
about 15–25 % bone volume. The intervening spaces are
gradually enlarged and become elongated in deeper re-
gions of the subchondral bone, forming the subarticular
spongiosa (Orth et al. 2013). Subchondral cortical and
cancellous bone are architecturally, physiologically and
mechanically different and respond differently in OA
(Burr & Gallant 2012).
Radin and co-workers first identified the subchondral
bone as a key factor in the initiation and progression of
OA (Radin et al. 1970, Radin et al. 1972), showing that
repetitive impulsive joint loading causes trabecular
microfractures in the subchondral bone. Repair of such
microfractures was thought to increase stiffness variation
in the subchondral bone and in turn, cause tension and
shear stress on the cartilage, ultimately leading to joint
degeneration. However, several investigations revealed
that the subchondral bone in OA is subjected to a de-
crease rather than an increase in bone stiffness (Burr
2004, Day et al. 2001). Besides, this strictly mechanical
approach and the historical interpretation of the role of
the subchondral bone can not explain the initial
Fig. 1 OA-associated changes in the human joint. Safranin O-stained histological sections from human normal versus OA knee joint cartilage are
presented on the top panels. The lower panel is a representation of the different tissues implicated in the OA pathology with crosstalks
Table 1 Lectures of the ICL16 on May 7th, 2016 of the 17th
ESSKA Congress in Barcelona, Spain
Speaker City Country Title of lectures
Magali Cucchiarini Homburg/Saar Germany Cell-matrix interface
in OA
Laura de Girolamo Milano Italy Animal models of OA
Giuseppe Filardo Bologna Italy Stem cells in OA
J. Miguel Oliveira Guimarães Portugal Tissue engineering
in OA
Patrick Orth Homburg/Saar Germany The bone in OA
Dietrich Pape Luxembourg Luxembourg High tibial osteotomy
models
Pascal Reboul Nancy France OA pathomechanisms
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subchondral bone loss observed in early OA, do not
allow for differentiation between early and late stages of
the disease, and do neither address biological aspects
nor the role of the calcified cartilage. Thus, a better in-
depth understanding of the complex processes involved
in OA is mandatory.
Current knowledge allows differentiation of two dis-
tinct pathophysiological processes: early and late stage
OA. Early OA is clinically defined as the combination of
joint pain, minor radiographic changes, but also pres-
ence of cartilage or subchondral bone lesions as seen
by arthroscopy or magnetic resonance imaging (Luyten
et al. 2012, Madry et al. 2016). Bone scintigraphic ana-
lyses (Buckland-Wright et al. 1991) or longitudinal
studies following anterior cruciate ligament rupture
(Buckland-Wright et al. 2000) suggest that subchondral
bone changes may precede articular cartilage degener-
ation in OA initiation.
Remodelling processes play the crucial role in the
pathogenesis of early OA and determine apparent sub-
chondral bone changes (Burr 2004). Here, activation of
secondary ossification centers, e.g. due to subchondral
microfractures, results in bone resorption by osteoclasts
followed by bone formation by osteoblasts. While this
remodelling sequence is strictly balanced under physio-
logical conditions, the rate of bone turnover is increased
three- to fivefold in early OA (Amir et al. 1992). Import-
antly, in such high rates of bone turnover, the late phase
of tissue mineralization is attenuated, leading to de-
creased bone stiffness (Goldring & Goldring 2010). En-
hanced vascularization of the subchondral bone plate
(Burr & Gallant 2012) causes decreased bone deposition
and reduced its thickness (Intema et al. 2010). Such de-
creased thickness has been confirmed in canine and
lapine experimental models of early OA (Bellido et al.
2011, Sniekers et al. 2008). Causes of increased bone
remodelling include cellular signalling processes for
microdamage repair (Funck-Brentano & Cohen-Solal
2011), stimulation of vascular invasion by angiogenic
factors (Pesesse et al. 2011), and disturbed bone-
cartilage crosstalk via physiological subchondral pores
(Duncan et al. 1987) or pathological microcracks (Burr
& Radin 2003).
The layer of calcified cartilage in normal joints is more
dense than bone and thinner than the overlying hyaline
articular cartilage (ratio 10:1) (Burr 2004). In early OA,
the calcified cartilage layer is subjected to increased en-
dochondral ossification (Suri & Walsh 2012), most likely
triggered by vascular invasion from the subchondral
bone compartment. In addition, recent experimental
data suggest that hypertrophic chondrocytes within the
calcified cartilage may transdifferentiate into osteoblasts,
thus directly obtaining the capacity for bone formation
(Yang et al. 2014, Zhou et al. 2014). Such ossification
results in an accelerated advancement and duplication
of the tidemark with increased thickness of the calcified
cartilage layer. This process may increase the mechan-
ical stress in the deep zones of the hyaline articular car-
tilage, contributing to the acceleration of OA (Goldring
& Goldring 2010).
In late stage OA, the bone remodelling sequence is
decreased and bone turnover is reduced. This allows
for an increase in bone deposition, resulting in an en-
hanced thickness of the subchondral bone plate and an
increased density of cortical and cancellous subchon-
dral bone (Burr & Gallant 2012). This phenomenon is
clinically known as subchondral sclerosis (Kellgren &
Lawrence 1957). Interestingly, osteoblasts in late stage
OA secrete a type-I collagen α1 homotrimer phenotyp-
ically distinct from the normal α1/α2 heterotrimer
(Chan et al. 2011, Couchourel et al. 2009) and posses-
sing a reduced affinity for calcium. This resolves the para-
dox of increased subchondral bone density relative to
decreased bone mineralization and stiffness in late OA.
OA pathomechanisms (focus on the subchondral
bone)
Early-stage OA increases remodelling and bone loss of
both trabecular and cortical subchondral entities (the
two parts of the subchondral bone), whereas late-stage
OA decreases remodelling and increases subchondral
plate densification (Burr & Gallant 2012).
Trabecular and bone plate are composed of osteocytes,
osteoblasts, and osteoclasts that function in a coordi-
nated manner during bone homeostasis. However, these
cells become malfunctioning during OA and most par-
ticularly the osteoblasts that acquire an OA phenotype
especially in advanced OA. Such OA osteoblastic pheno-
type is more marked in the subchondral bone plate than
in the trabecular bone, located at one centimeter of the
cortical plate (Lavigne et al. 2005), and consisting in the
up-regulation of numerous genes coding for extracellular
matrix proteins, secreted cytokines and growth factors,
and cell membrane proteins. For instance, interleukins 6
and 8 (IL-6, IL-8), leptin, and prostaglandins E2 (PGE2)
are inflammatory factors secreted in a higher amount by
OA osteoblasts (Hilal et al. 1998, Lisignoli et al. 2006,
Massicotte et al. 2002, Mutabaruka et al. 2010). Type-I
collagen (the major protein of the osteoid matrix) as well
osteocalcin and osteopontin (proteins involved in matrix
mineralization) are also produced in higher quantity
(Gevers & Dequeker 1987, Hilal et al. 1998, Sanchez
et al. 2008). However, OA bone is undermineralized
(Grynpas et al. 1991), probably due to a defect of osteo-
blast function (Couchourel et al. 2009, Taylor et al.
2014). One explanation of this phenomenon could be
that although type-I collagen production is increased
(Mansell & Bailey 1998), the presence of homotrimers of
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alpha 1 chain of type-I collagen (Couchourel et al. 2009)
instead of the classical 2-to-1 ratio of alpha 1 and alpha
2 chains disturbs the mineralization. Dickkopf-related
protein 2 (DDK2) and sclerostin (SOST) whose expres-
sion increases, while that of R-spondin 2 (R-Spo2)
decreases, seem also to play a role in the hypominerali-
zation of OA bone (Abed et al. 2011, Abed et al. 2014,
Chan et al. 2011). Interestingly, DKK1 is not differen-
tially expressed between normal and OA osteoblasts
(Chan et al. 2011). In addition to these factors, some cell
membrane proteins involved in the balance of inorganic
pyrophosphate and phosphate ions, namely alkaline
phosphatase and ANKH (an inorganic pyrophosphate
transport regulator) are upregulated during OA (Hilal et
al. 1998, Sanchez et al. 2008). OA osteoblasts produce
high level of growth factors such as transforming growth
factor beta (TGF-β) (Mansell & Bailey 1998), insulin-like
growth factor I (IGF-I) (Hilal et al. 1998, Massicotte et
al. 2002), and hepatocyte growth factor (HGF) (Guevre-
mont et al. 2003) as well as leptin (Mutabaruka et al.
2010) that may intervene in the modifications of the
behavior of the articular chondrocyte through diffusion
via microcracks. For example, TGF-β can either stimu-
late (Smad1/5/8 signaling pathway) or inhibit (Smad2/3
signaling pathway) chondrocyte terminal differenti-
ation. There is further evidence that a switch in TGF-β
signaling from Smad2/3 to Smad1/5/8 signaling plays a
role in altered articular chondrocyte behavior and in
the development of OA (van der Kraan et al. 2009). It
was also shown that HGF can upregulate the expression
of collagenase 3, a very active enzyme directed against
type-II collagen (Reboul et al. 2001) whereas leptin is
associated with OA cartilage (Dumond et al. 2003). Al-
though the presence of these microcracks and of a
greater number of blood vessels, OA subchondral bone
undergoes hypoxic conditions. Very few studies have
addressed hypoxia as measuring oxygen tension in the
bone is arduous. However, venous stases (Arnoldi et al.
1972) have long been reported in OA patients and have
been confirmed more recently with dynamic contrast-
enhanced magnetic resonance imaging (MRI) (Aaron
et al. 2007) and positron electron transfer (Dyke &
Aaron 2010), sometimes leading to intra-osseous hyper-
tension (Arnoldi et al. 1972). These perfusion abnor-
malities have also been associated with osteonecrosis
and bone marrow lesions (Aaron et al. 2007) as
dynamic episodes seen with MRI, often predicting
progressive OA (Driban et al. 2013, Hunter et al. 2011,
Pelletier et al. 2013, Xu et al. 2012).
Hypoxic conditions induce a high level of leptin pro-
duction by osteoblast particularly under the control of
vitamin D (Bouvard et al. 2014).
Cell signaling in OA osteoblasts is disturbed too. For
instance, OA osteoblasts show blunted cAMP synthesis
in response to human parathyroid hormone and PGE2 in
contrast to findings in normal cells, a result that is not
attributed to altered adenylate cyclase activity (Hilal et
al. 1998). Upon IGF-I stimulation, the phosphorylation
of the IGF-I receptor (IGF-IR) is normal while that of
the insulin receptor substrate 1 (IRS-1) is reduced in
OA osteoblasts. In addition, the p42/44 mitogen-
activated protein kinase (MAPK) pathway is higher in
OA versus normal osteoblasts. This pathway can be trig-
gered via IRS-1/Syp (the protein tyrosine phosphatase,
non-receptor type 11) or growth factor receptor bound
protein 2 (Grb2)/Src-homology collagen (Shc) interac-
tions. Syp is highly phosphorylated in OA osteoblasts
and its interaction with IRS-1 is very strong initially, yet
rapidly dropped in the presence of IGF-I. The inter-
action of Grb2 with IRS-1 progressively increases in
response to IGF-I in OA osteoblasts whereas this is ab-
sent in normal osteoblasts. This dysregulation is respon-
sible for the fact that OA osteoblasts are more prone to
proliferation than normal ones (Massicotte et al. 2006).
Another important signaling pathway affected by OA is
the Wnt (wingless-type MMTV integration site family
member) signaling route and particularly the canonical
Wnt/β-catenin signaling that is reduced. When correct-
ing DKK2 levels in OA osteoblasts either directly by
small interfering RNA (siRNA) techniques or indirectly
by ablating the TGF-β amount, Wnt/β-catenin signaling
activity is recovered (Chan et al. 2011). Conversely, when
adding R-Spo2 to osteoblast cultures as a means to
counteract their own weak production, Wnt/β-catenin
signaling activity is also recovered (Abed et al. 2011).
Like DDK2, R-Spo2 is under the control of TGF-β. Wnt/
β-catenin signaling activity is also decreased by overpro-
duction of SOST that is controlled by a low sirtuin 1
activity in OA osteoblasts (Abed et al. 2014). Phenotypic
disturbance of OA osteoblast regarding Wnt signaling
pathway is summarized in Fig. 2. TGF-β is a key player
in the process and is regulated by HGF and leptin, them-
selves under the regulation of hypoxia. This latter can
also directly induce TGF-β production.
In summary, the OA osteoblastic phenotype in
cortical subchondral bone is more marked than in the
trabecular one. Parathyroid hormone (PTH), IGF-I, and
Wnt signaling and may be other pathways are dis-
turbed. The right interaction between osteoblasts and
the modified OA extracellular cartilage matrix (ECM) is
disturbed too. TGF-β could be a key player in the
process of OA in subchondral bone and hypoxia an
aggravating factor of risk.
Cell-matrix interface in OA (focus on the articular
cartilage)
Cartilage degeneration is a hallmark of OA (Malemud
et al. 1987). The articular chondrocytes are the only cell
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population present in the adult hyaline cartilage, the
avascular, aneural tissue responsible for a smooth gliding
of articulating surfaces. These cells are embedded within
their ECM (mostly type-II collagen for tensile strength
and proteoglycans with water for stiffness in compres-
sion/resilience) in three major, differently organized
zones (Fig. 3a): a superficial (tangential) zone (cells
parallel to the surface), a middle zone (spherical cells
randomly organized), and a deep zone (columnar cells
perpendicular to the surface). A calcified zone follows
(small cells and type-X collagen fibrils), separated from
the subchondral bone (subchondral bone plate and sub-
articular spongiosa) by the cement line. A narrow matrix
surrounds the chondrocyte, namely the pericellular
matrix (PCM) that is rich in perlecan, aggrecan mono-
mers and small aggregates, hyaluronan, biglycan, colla-
gens (type-VI and -IX collagen compared with the
ECM), and fibronectin, followed by the territorial and
interterritorial zones (Heinegård 2009, Poole et al. 1988,
Wilusz et al. 2014) (Fig. 3b). In OA, as a result of
various factors (pathological loading, obesity, aging, joint
instability, repetitive stress injury, inflammation, genetic
background), the cartilage becomes fibrillated in the
superficial zone (loss of proteoglycans, reduction in
water content, decreased elasticity) while cracks extend
through the middle zone (formation of vertical matrix
clefts, erosion of the collagen fibers), leading to cartilage
breakdown towards the subchondral bone that becomes
exposed and may be also deformed (Fig. 4a), with critical
degradative changes also noted in constituents of the
PCM (Heinegård & Saxne 2011) (Fig. 4b) and in associ-
ation with synovial inflammation characterized by the
production and release of inflammatory mediators and
catabolic agents (cytokines: interleukin 1 beta - IL-1β
and tumor necrosis factor alpha - TNF-α; chemokines:
IL-8; proteinases: matrix metalloproteinases - MMPs -
and aggrecanases; other mediators: PGE2, cyclooxygen-
ase 2 - COX2, nitric oxide - NO, advanced glycation end
products - AGEs) (Goldring & Otero 2011).
The chondrocytes are key cells implicated in the main-
tenance of the cartilage homeostasis by tightly control-
ling the production and degradation of ECM components
according to the environment conditions in the joint
(Goldring & Goldring 2007). They are capable of sensing
biochemical and biomechanical stimulation to adapt the
metabolic balance via interactions with PCM components
that afford protection to the cells during loading (Goldring
& Goldring 2007, Goldring & Otero 2011, Guilak et al.
2006). In normal adult cartilage, the chondrocytes are
resting cells with a phenotypic stability characterized by a
post-mitotic vitality with low metabolic activities (moder-
ate matrix turnover) (Fig. 5), responding to physiological
Fig. 2 Factors regulating Wnt signaling in OA osteoblasts (modification from the original drawing representing the canonical Wnt route adapted
from Baron & Kneissel 2013). APC, Adenomatous polyposis coli; DKK2, Dickkopf-related protein 2; DVL, Dishevelled protein; FZD, frizzled receptor;
GSK3, glycogen synthase kinase 3; HGF, hepatocyte growth factor; LEF, lymphoid enhancing factor; LPR, lipoprotein receptor-related protein;
R-Spo2, R-spondin 2; TCF, T-cell factor; TGF-β, transforming growth factor beta
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biochemical and biomechanical activation via membrane
sensors that are also receptors for PCM molecules
(Goldring & Goldring 2007, Guilak et al. 2006). Among
them, the integrins are receptors for fibronectin and type-II
and -VI collagen (Enomoto et al. 1993, Loeser 2014) acting
with syndecan-4 as a co-receptor (Echtermeyer et al. 2009),
discoidin domain receptor 2 (DDR-2) for type-II and -X
collagen (Labrador et al. 2001, Lam et al. 2007, Leitinger &
Fig. 3 Organization of the normal adult articular cartilage. a Organization of the chondrocytes in their ECM in superficial, middle, and deep zones.
The cement line separates the calcified zone from the subchondral bone. Major ECM components are presented in the box. b Normal PCM and
cell-matrix interface (adapted from Heinegård & Saxne 2011)
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Kwan 2006), and CD44 for hyaluronan (Knudson 1993)
(Fig. 6). Other mechanosensors include primary cilia,
connexin 43, Indian hedgehog (Ihh), and the transient re-
ceptor potential vanilloid 4 (TRPV4) for collagens and
proteoglycans (Knight et al. 2009, McGlashan et al. 2006,
Muhammad et al. 2012, O’Conor et al. 2016, Ruhlen &
Marberry 2014, Shao et al. 2012). In OA, the cells undergo
phenotypic modifications reproducing those occurring
during skeletal development (activation of cell proliferation
processes, cell clustering, disruption of the metabolic
Fig. 4 Pathological organization of OA cartilage. a Disrupted organization. b OA PCM and altered cell-matrix interface (adapted from Heinegård &
Saxne 2011)
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balance with both abnormal matrix production and degrad-
ation, hypertrophy, and calcification) (Fig. 5) (Goldring &
Goldring 2007, Loeser et al. 2012). Altered interactions
between chondrocytes and PCM constituents are critical
components of the pathogenesis of OA. As a result of
cartilage matrix fragmentation, interactions between mem-
brane sensors/receptors and PCM molecules become
altered, leading to abnormal cell signalling that promotes
the activation of matrix-degrading enzymes (MMPs, a
disintegrin metalloproteinase with thrombospondin motifs
- ADAMTS) and inflammatory cytokines or chemokines
(IL-1β, TNF-α, NO, AGEs) and to the pathological release
of mediators otherwise interacting with natural PCM
elements that serve as a reservoir for such agents
(vascular endothelial growth factor - VEGF, TGF-β,
bone morphogenetic proteins - BMPs, basic fibroblast
growth factor - FGF-2, IGF-I, epidermal growth factor -
EGF, cartilage-derived morphogenetic protein 1 -
CDMP-1) that may further stimulate OA-associated
cascades (cell differentiation, hypertrophy, cytoskeletal
reorganization, cell senescence, complement activation,
altered autophagy…) (Arner & Tortorella 1995, Forsyth et
al. 2002, Pulai et al. 2005, Stanton et al. 2002, Xu et al.
2007) (Fig. 6). Similar pathological changes and effects
may also affect other cells relevant of the pathogenesis of
OA, including synovial fibroblasts and bone cells as all
joint tissues undergo phenotypic modifications in this
disorder (Loeser et al. 2012), reflecting the high level of
complexity and key involvement of cell-matrix interac-
tions in human OA.
Fig. 5 Cartilage homeostasis. Natural and pathological OA cellular and metabolic balance
Fig. 6 Cell-matrix interface in OA. Interactions between membrane sensors/receptors at the surface of chondrocytes become altered during OA,
leading to abnormal signalling and activation of OA-related pathways via integrins (a), syndecan-4 (b), DDR-2 (c), and CD44 (d)
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Animal models of OA
The growing interest in both the factors triggering the
development of OA and the therapeutic targets enabling
more effective treatments has led to the introduction of
a large number of animal models, depending on the
many different aspects of human pathology. Each model
can indeed describe only few peculiar aspects of the path-
ology and should be chosen accurately so as to maximize
the outcome and the translatability of each study.
Primary OA is better monitored using naturally occur-
ring models such as spontaneous and overuse-induced
OA or genetically-induced OA whereas secondary OA
can be mimicked by invasive surgical techniques such as
meniscectomy, anterior cruciate ligament transaction
(ACLT), or by chemical induction with inflammatory me-
diators or degenerative agents. Animal size and features
are also crucial parameters for the study design. Although
small animals allow for an easier and less costly manage-
ment, their restricted size and differences with the human
anatomy, histology, and physiology actually represent a
limit to the translatability and investigation with radiologic
techniques. On the other hand, large animals offer the ad-
vantages of spontaneous or readily inducible OA and of
closer similarity to the human organism but at the same
time, the high costs and negative public perception repre-
sent relevant drawbacks (Gregory et al. 2012).
During a study design, it is also important to adopt
the model that better represents the pathology of inter-
est so that the most suitable analyses can be performed.
In OA, the most examined joint is the knee, however
some models have been developed in metacarpophalangeal
(McCoy 2015) and middle carpal joints (McIlwraith et al.
2010) of horses. When treating primary OA, naturally oc-
curring models seem better suited since the disease spon-
taneously arises and simulates the natural progression of
human pathology. In this model, one advantage is repre-
sented by the similarity between the experimental lesions
and those occurring in human patients. Several animals
have been proposed including mice, guinea pigs, rabbits,
dogs, sheep, goats, and horses (Kuyinu et al. 2016, McCoy
2015). Guinea pigs represent a particularly good model to
study human primary OA because of its rapid onset de-
velopment (Yan et al. 2014). Horses are instead the
most similar model to human individuals in terms of
structure and pathology features and thus represent a
valid system to study bone remodeling. Nevertheless,
two major drawbacks of these models are represented
by the long time needed for injury development and
their high costs. Another way to obtain reliable models
of primary OA is to use genetically-modified animals.
This approach is useful to investigate the molecular
basis of OA such as the effect of pro-inflammatory cy-
tokines on its development (Little & Hunter 2013). Still,
the complexity of this multifactorial pathology reduces
the translatability to clinical practice of data derived
from genetically-modified animals because therapeutic
interventions targeting these specific genes do not take
into account other contributing genes that participate
in the pathogenesis of the disease (Miller et al. 2013).
Secondary OA commonly develops as a consequence
of a traumatic event (post-traumatic OA) or as a result
of other causes such as congenital conditions or bone
disorders (Brown et al. 2006). This type of OA can be
modeled by invasive (surgically- or chemically-induced
OA) or non-invasive techniques (Table 2). Surgical
models are usually adopted to study the drug effect on
the disease process (Lampropoulou-Adamidou et al.
2014). These approaches ensure a rapid development of
the pathology whereas their lack of correlation to natural
degenerative changes in human OA represent a clear
disadvantage. A typical surgical model is ACLT that
causes joint destabilization leading to articular cartilage
degeneration. The preferred animals adopted in this kind
of model are the sheep and goat. Compared with men-
iscectomy, the OA lesions occurring in ACLT develop
more slowly, making this approach more suitable for use
in pharmacological studies (Proffen et al. 2012). A total
or partial meniscectomy produces a great destabilization
of the joint, thus leading to a rapid degeneration and a
more severe pathology (McDermott & Amis 2006). A
common model of OA in the mouse is the surgical
destabilization of the medial meniscus (DMM) which
leads to mild to moderate OA lesions primarily located
in the anterior-central portion of the medial joint, with
lesions on both the tibial plateau and femoral condyles
(Glasson et al. 2007). Two other surgical models are rep-
resented by the medial meniscal tear model (transection
of medial collateral ligament) which causes a proteogly-
can and chondrocyte loss leading to cartilage degener-
ation and is generally performed in guinea pigs and rats
(Glasson et al. 2007, McCoy 2015) and ovarectomy
which is particularly indicated to investigate post-
menopausal changes such as osteoporosis, eventually
leading to OA (Martín-Millán & Castañeda 2013).
Table 2 Invasive and non-invasive models
Invasive models Non-invasive models
Advantages rapid induction, high reproducibility, readily available,
widely described systems
rapid induction, high reproducibility, low infection risk, long time
frame of OA changes, allowing for early evaluation and intervention
Limitations risk of infection, expertise needed, early changes often,
undetectable because of rapid induction
not readily available, expertise needed, scarce literature
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Another invasive way to induce OA is represented by
the use of chemical compounds. It consists of the direct in-
jection of toxic or inflammatory compounds into the joint
such us papain, collagenase, sodium monoiodoacetate, and
quinolones (bacterial arthritis) (Kuyinu et al. 2016).
Among the non-invasive models, the use of devices
causing injury through controlled compressive loading
and mechanical impact is the most common approach
to produce over injury to a joint structure and promote
OA. Such systems produce an external insult to the joint
without the need of any chemical or surgical interven-
tion, avoiding the risks of infection or of uncontrolled
inflammation and allowing the creation of standardized
injuries. Examples of non-invasive models are intra-
articular tibial plateau fractures that reproduce post-
traumatic OA from high energy impact and cyclic
articular cartilage tibial compression mimicking chronic
joint overuse (Christiansen et al. 2015). Application of
adjustable mechanical loads and cyclic compression rep-
resent other alternatives to modify the cartilage structure
and contribute to OA (Ko et al. 2013, Poulet et al. 2011).
The choice of the right procedure to induce OA, as well
as of the most adapted animal model depends on many
factors such as the technical feasibility and the type of
the pathology of interest since it could involve different
development, progression, response to treatments, hous-
ing time and costs, animal amenability, and preferred
outcome measurements (Table 3).
Another important aspect to take into account dur-
ing the study design is the outcome of measurements.
Quantitative methods comprise the evaluation of bio-
markers, precursors, and products of metabolism re-
leased in the serum, urine, and synovial fluid whose
levels can correlate with OA changes occurring in the
joint. Histopathology and imaging like X-rays and
MRI are suitable qualitative methods (Eckstein & Le
Graverand 2015) that can be adopted together with
appropriate histopathological scores such as the Mankin,
O’Driscoll, International Cartilage Repair Society (ICRS),
and Osteoarthritis Research Society International (OARSI)
scores in order to provide a quantitative interpretation of
the results.
In conclusion, translational animal research plays critical
roles in helping researchers to understand the mecha-
nisms of the disease, in improving the methods of early
detection, and in identifying and investigating potential
treatment targets for such a common, complex pathology
as OA. From this point of view, it is crucial to identify and
apply the most suitable model to each single research
purpose in order to maximize translatability and comply
with ethical an economical requirements. However,
despite the potentiality of these models, the results arising
out of preclinical studies have shown poor translation into
clinical trials. One of the reasons could be that most
studies involve post-traumatic OA, but the generated
therapeutic intervention is then used to treat primary OA.
Clearly defined post-traumatic OA in humans based on
evaluations by MRI and other sensitive imaging approaches
may represent a useful, more adapted clinical cohort for
proof-of-principle for human trials. Moreover, a non-
homogeneous data collection in these studies (animal
husbandry conditions, animal gender…) could generate
confusion and reduce the reliability of a study comparison.
To improve uniformity and make the results more repro-
ducible, it is strongly suggested to follow the Animal
Research Reporting of In Vivo Experiments (ARRIVE)
guidelines as well as to include skilled researchers, such as
veterinary technicians and doctors in the research team.
High tibial osteotomy models
Preclinical large animal models of high tibial osteot-
omy (HTO) can be used to test different types of
osteotomies and to evaluate the effect of lower limb
alignment on the reconstructive therapy of cartilage
lesions and on the development and progression of
OA (Allen et al. 1998, Lobenhoffer & Agneskirchner
2003).
Table 3 Animal models
Animal Size Advantages Limitations Applications
Mouse very small low cost, amenability,
standardized variants
post-operative management,
low translability
chemically- and genetically-induced OA
Guinea pig very small low costs, similarity
with human OA
sedentary behaviour,
low translability
spontaneous and chemically-induced OA
Rat small low cost, amenability post-operative management surgically- and chemically-induced OA
Rabbit small amenability self-regeneration, differences
with human anatomy,
post-operative management
surgically- and chemically-induced OA
Dog medium/large radiologic evaluation high costs, perception spontaneous and surgically-induced OA
Sheep/goat large amenability, radiologic
evaluation, large joints
high costs, physiology meniscectomy
Horse large radiologic evaluation high costs, anatomy, perception spontaneous OA and overuse
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Although many of our experimental knowledge on
osteotomies is based on cadaver studies (Lim et al.
2011), the sheep as a preclinical, large animal model of
HTO has not been described. Our goal was thus to es-
tablish such an HTO model as a means to study the ef-
fect of axial alignment on the lower extremity on
specific issues of the knee joint such as in cartilage re-
pair, development of OA, and meniscal lesions. Thirty-
five healthy, skeletally mature, female Merino sheep
underwent an HTO of their right tibia in a medial open-
wedge technique inducing a normal (group 1, n = 12)
and excessive valgus alignment (group 2, n = 12) and a
closed-wedge technique (group 3, n = 11). The aim of
surgery was to elucidate the effect of limb alignment on
cartilage repair in vivo. The surgical technique as well as
the clinical results have been published previously (Pape
& Madry 2013). Severe post-operative complications oc-
curred within 2–21 days after surgery. Two sheep were
euthanized due to instability of the osteotomy that arose
as a consequence of performing a monocortical fixation
of the proximal screws (Fig. 7). Another sheep was eutha-
nized after 4 days because of chronic patella dislocation
caused by excessive valgus osteotomy and subsequently
insufficient closure after medial arthrotomy (n = 1). Three
intra-articular infections were noted 2–4 days after sur-
gery, one infection in each osteotomy group. Although
immediate revision with debridement was performed, all
animals had to be euthanized 3–5 days after the surgical
revision due to a progression of the systemic infection.
In summary, solid bone healing and maintenance of
correction are most likely to occur using the following
surgical principles:
. medial and longitudinal approach to the proximal tibia,
. biplanar osteotomy to increase initial rotatory
stability regardless of the direction of correction
(Pape et al. 2013),
. small, narrow but long implant with locking screws
(small stature HTO plate, Synthes, Umkirch,
Germany) (Fig. 8),
. posterior plate placement to avoid slope changes, and
. use of bicortical screws to account for the brittle bone
of the tibial head and to avoid tibial head
displacement (Tables 4 and 5).
Although successful HTO in sheep is complex, this
model may serve as an elegant model to induce axial
malalignment in a clinically relevant environment and
osteotomy healing under challenging mechanical condi-
tions due to its similarities with humans.
Stem cells in OA
Mesenchymal stem cells (MSCs) are considered a promis-
ing option for the treatment of OA. MSCs are multipotent
progenitor cells with capability of self-renewal, high plasti-
city, immunosuppressive and anti-inflammatory action, and
the possibility to differentiate into selected lineages includ-
ing chondrocytes (Manferdini et al. 2013). Moreover, these
cells, derived from perivascular cells called "pericytes", play
a key role in the response to tissue injury not only by differ-
entiating themselves but also by inducing repair/regener-
ation processes at the site of damage through the secretion
of several bioactive molecules (Caplan & Correa 2011).
However, despite extensive preclinical research and
promising findings reported in the clinical practice upon
surgical application or via minimally invasive treatments
through intra-articular injections (Filardo et al. 2013),
both their potential and limitations for a thorough use
in patients remain controversial (de Girolamo et al. 2016).
Different cell sources have been explored as solutions for
cartilage lesions and OA treatment such as bone marrow,
adipose tissue, synovial tissue, and peripheral blood.
Altogether, a recent systematic review identified 60 studies
of which only seven were randomized (Filardo et al. 2016)
Fig. 7 Late sequela of a monocortical screw fixation. Left: caudal view on a cross-sectional area of the proximal tibial segment showing monocortical
screw imprints of the tibial head. Right: Post-operative X-ray of the right sheep tibia shortly after an open wedge HTO in a foundering animal with a
secondary dislocation of the tibial head (from Pape & Madry, 2013)
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(Table 6). On the other hand, the available studies allow to
draw some indications. First, no major adverse events have
been reported. Second, a clinical benefit has been shown in
most of the studies regardless of the cell-source processing
method and clinical indication, with clinical improvements
and also positive MRI and macroscopic findings. Moreover,
some factors that may influence the outcome have been
identified, such as age, body mass index (BMI), lesion size
or degenerative stage. Beside the many still open questions
in terms of the choice of cell source, the best processing
method, the dose and administration method as well as the
best treatment indications, the overall results also under-
lined only a partial benefit provided by this biological ap-
proach to treat early OA stages, both in terms of
uncomplete recovery and compared with the benefit ob-
tained with other available treatment options.
Basic science results may be useful to understand the
suboptimal results obtained clinically so far and to help
identifying development strategies for future directions to
improve OA treatments. The safety of using MSCs is
supported by preclinical studies but some risks have been
also underlined such as the possibility of contamination
during cell manipulation and the formation of free body
and scar tissue in the joint with the transplantation of
large cell numbers (Agung et al. 2006). The risk of
unwanted differentiation and inadequate aging is another
possibility strictly related to the treatment efficacy
itself. In fact, signs of hypertrophy have been docu-
mented with MSC chondrogenic differentiation: type-X
collagen, MMP13, alkaline phosphatase (ALP) are signs
of terminal differentiation that may lead to
mineralization in vivo and thus to the formation of a
low quality cartilage (Hellingman et al. 2012). These
findings have been documented not only in bone
Fig. 8 Plate design is crucial to meet the anatomical requirements of
the sheep tibia. Proximally narrow, long and rigid plates (TomoFix small
stature plate, Synthes, left) are advisable as opposed to anatomically
shaped and broad plate designs (ContourLock, Arthrex, right) which fail
to cover the sheep anatomy and may produce soft tissue impingement
(from Pape & Madry, 2013)
Table 4 Surgical anatomical parameters relevant for HTO in humans and sheep
Human knee Sheep stifle joint Surgical consequences for the sheep
HTO model
Tibial plateau width [mm] 60-70 46-56 match screw length, narrow and strait plate
design necessary
Tibia valga [°] 0 3.5 valgus overcorrection more likely
Knee range of motion [°] 0-0-140 0-35-72 dorsal plate positioning after open wedge
HTO suggested due to increased loading
of the posterior tibial plateau
Tibial tuberosity dimension adding
to the anterio-posterior diameter of
the tibial head [%]
10-15 30-35 anterior plate misplacement more likely
Tibial tuberosity height distance
in relation to the joint line [mm]
25-30 10-15 anterior plate misplacement more likely
Posterior slope of the posterior
articular surface [°]
0-10 20 ± 3 narrow and straight plate design necessary
for posterior placement
Biomechanical properties of the
tibial head
elastic cortical bone, exuberant
amount of spongious bone
brittle cortical bone, few
spongious bone
bicortical proximal screw placement
mandatory to avoid fracture and dislocation,
biplanar osteotomy mandatory regardless
of the desired direction of correction
Musculature of the hind limb remote from bony knee
structures
voluminous on medial and
lateral side of the femur
distal femoral and proximal lateral tibial
osteotomy almost impossible, stay on the
medial side of the proximal tibia for any
desired correction angle
Trochlea ridge lateral ridge extending further
laterally and anteriorly
medial ridge extending further
cranially and dorsally than lateral
ridge
higher propensity of patella instability after
valgus correction
Case reports: + (seldom), ++ (infrequent), +++ (frequent), 1 (may depend on implant design)
° degree
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marrow-derived cells but also when dealing with adi-
pose tissue and even with embryonic stem cells, sug-
gesting that the current culture conditions may be not
ideal to guide MSCs toward chondrogenic differenti-
ation. Different strategies have been proposed to inhibit
terminal differentiation but nowadays no hyaline cartil-
age regeneration can be obtained in vitro, yet, and
therefore no hyaline cartilage may be expected in vivo
(Hellingman et al. 2012). Other indications from the
preclinical literature relate to the number of cells and
the need for either expansion or concentration. Hetero-
geneous findings do not allow to drag clear conclusions
on this matter but the need to obtain many cells
through expansion has been questioned by studies
showing similar or even better results through the use
of concentrates which may offer a lower number of
cells but on the other hand the benefit of administering
MSCs in their niche and therefore allowing them to act
in more favorable conditions (Perdisa et al. 2015, Wu
et al. 2016). Regardless of the cell type and method of
manipulation, MSCs are rarely applied in clinical prac-
tice alone and platelet concentrates have been frequently
associated to their use. Even though no randomized con-
trolled trials has been performed to demonstrate the
added benefits of blood-derived products, basic science
supports platelet-rich plasma (PRP) combination, showing
a synergistic effect through cell-proliferation and extracel-
lular synthesis, anti-inflammatory effects, and in the end
lower OA progression (Yun et al. 2016).
In conclusion, the state of the art of MSCs for the
treatment of OA shows contrasting findings. While
promising results have been obtained in terms of clin-
ical improvement, results are not optimal and there is
still a lack of indication on the optimal cell source, pro-
cessing, and administration modality. Further studies
are needed both preclinically to develop appropriate
models to further explore the potential of MSCs as well
as in the clinical practice through randomized con-
trolled trials to clearly demonstrate the advantages of
this biological approach with respect to the other avail-
able treatments for OA.
Tissue engineering in OA
The ideal treatment for OA should control not only
the symptoms but also slow down or prevent the deg-
radation of the joint. In this sense, tissue engineering
may be a game changer in the treatment of OA as it
can possibly create functional substitutes through
Table 5 Probabilities of potential pitfalls among humans and
sheep
Structure Human Sheep
Neurologic injuries ++ -
Osteonecrosis of proximal fragment ++ -
Fracture through proximal fragment with
violation of the joint space
++ -
Infection + +++
Vessel injury + ++
Bone cysts without screw perforation - +
Compartment syndrome + -
Non-union + -
Loss of correction due to implant failure 1 +
Overcorrection 1 -
Case reports: + (seldom), ++ (infrequent), +++ (frequent), 1 (may depend on
implant design)
Table 6 Stem cells for OA treatment: clinical evidence from randomized controlled trials
Treatment Procedure Patients Follow-up Outcomes References
BMSCs i.a. 15
(versus HA)
1 year improved function,
higher cartilage quality
(MRI)
Vega et al. 2015
BMSCs (HA) i.a.
(meniscectomy)
18
(low versus high MSCs
dose versus HA)
2 years pain improvement,
meniscus regeneration
(MRI)
Vangsness et al. 2014
BMSCs
(HA)
i.a.
(osteotomy and microfracture)
28
(versus HA)
2 years clinical improvements,
higher cartilage quality
(MRI)
Wong et al. 2013
BMCs
(matrix/PEMF)
surgical delivery
(collagen matrix)
15
(versus matrix)
1 year improved recovery Cadossi et al. 2014
PBSCs
(HA)
i.a.
(drilling)
25
(versus HA)
2 years improved cartilage quality
(MRI)
Saw et al. 2013
ASVF surgical delivery
(microfracture)
40
(versus microfracture)
2 years clinical improvements,
higher cartilage quality
(MRI)
Koh et al. 2016
ASVF
(PRP)
i.a.
(osteotomy)
21
(versus PRP)
2 years clinical improvements,
fibrocartilage coverage
Koh et al. 2014
Abbreviations: MSCs mesenchymal stem cells, BMSCs bone marrow-derived MSCs, HA hyaluronic acid, BMCs bone marrow concentrates, PEMF pulsed electromagnetic
field, PBSCs peripheral blood stem cells, ASVF adipose stromal vascular fraction, PRP platelet-rich plasma, i.a. intra-articular
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integrated solutions where scaffolds, cells and drugs/
growth factors are used, alone or in combination
(Langer and Vacanti 1993).
Cell-free implants consisting of matrices and/or local
factor delivery systems for progenitor cell recruitment
and differentiation have been investigated. The process
can promote the recruitment of MSCs from the bone
marrow or synovium into a defect-filling chondroinduc-
tive matrix where they form new cartilage. Microfracture
can be also applied to create small channels between the
defect and subchondral bone to improve the contact be-
tween the defect and bone marrow (Ringe et al. 2012).
In situ stem cells administration by intra-articular injec-
tion can result in the engraftment of cells on the menis-
cus, fat pad, and synovium with regeneration of
meniscal tissue and protection of the cartilage, but no
engraftment has been seen on the fibrillated cartilage
surface (Murphy et al. 2003). Vectors have been used for
ex vivo intra-articular gene delivery. It has been reported
that hydrated collagen-glycosaminoglycan matrices con-
taining adenoviral vectors promote localized reporter
gene expression in vivo for at least 21 days after implant-
ation into osteochondral defects localized in rabbit knees
(Pascher et al. 2004). Interestingly, the delivery of au-
tologous chondrocytes or of MSCs for cartilage regener-
ation may be promising when envisioning to treat early
OA upon hydrogel administration (Vilela et al. 2015).
This can be performed directly after debridment in the
knee articular cavity or at damaged sites in order to im-
prove mechanical stability of cartilage while facilitating
tissue regeneration. The advantages of hydrogel systems
are as follows:
. they are made of a three-dimensional (3D) permeable
polymer network,
. they are produced by a reaction of monomers or by
hydrogen bounding,
. they exhibit a hydrophilic structure making them
capable of holding large amounts of water (thousands
of times their dry weight),
. their mechanical properties (e.g. stiffness) can be
tuned according to the application,
. they have free-shapeable properties (bending, knotting
stretching, compressing),
. they can be injected in minimally invasive manner,
. they have an ability to encapsulate and control the
delivery of cells and growth factors, and
. they are bioadhesive and biocompatible.
Table 7 summarizes the relevant studies dealing with
the application of hydrogels in early OA as cell/drug de-
livery carriers.
Our group has proposed the use of gellan gum (GG)
hydrogel, a linear anionic exopolysaccharide (molecu-
lar mass: ~ 106 g/mol) that exists in two forms (high
acyl - HA, low acyl - LA) for cartilage tissue engineer-
ing (Oliveira et al. 2010). GG hydrogels are promising
systems for OA treatment strategies as:
. they can be used as injectable systems for minimally
invasive surgeries,
. they allow for gelation in the presence of body fluids
within few seconds,
. they display some degree of bioadhesiveness while
allowing cells encapsulation, proliferation, and
differentiation towards the chondrogenic lineage, and
. they are noncytotoxic.
The methacrylated GG derivative (GGMA) has been
synthesized and processed in the form of hydrogel and
scaffolds (single or multilayered) to deliver cells and
drugs for cartilage regeneration (Pereira et al. 2014).
These systems are now also being tested in preclin-
ical assays to provide a valid alternative to hyaluro-
nan in VS strategies and cell delivery for the
treatment of early OA. GG-based hydrogel systems
are valuable technological platform for the delivery
of stem cells using minimally invasive techniques as
it is an injectable system that mimics the native car-
tilage ECM.
Table 7 Application of hydrogels as cell/drug delivery carriers for OA therapy
Hydrogels Objectives References
HA injection of autologous MSCs in goat knee joints (Murphy et al. 2003)
PlnD1-HA microgel injection of PlnD1-HA to potentiate BMP-2 activity
in an experimental murine OA model
(Srinivasan et al. 2012)
Alginate-chitosan beads injection of beads to reduce OA in rabbits (Oprenyeszk et al. 2013)
Kartogenin-conjugated chitosan hydrogel intra-articular delivery to protect against OA in rats (Kang et al. 2014)
Fibrin/HA-MA hydrogel induction of bone marrow-derived MSCs chondrogenesis (Snyder et al. 2014)
Gelatin hydrogels incorporating rapamycine micelles intra-articular administration to protect against OA in mice (Matsuzaki et al. 2014)
CM-SIN and GelMA hydrogels intra-articular injection to reduce OA in mice (Chen et al. 2016)
Abbreviations: HA hyaluronic acid, PlnD1 perlecan module, MA methacrylic anhydride, CM-SIN sinomenium encapsulated in chitosan microspheres, GelMA gelatine
methacrylate, MSCs mesenchymal stem cells, BMP-2 bone morphogenetic protein 2, OA, osteoarthritis
Cucchiarini et al. Journal of Experimental Orthopaedics  (2016) 3:22 Page 14 of 18
Future tissue engineering approaches using hydrogels
in OA should:
. be patient-specific,
. be based on a single step surgical procedure,
. exploit the combination of different cell types (e.g.
co-administration of stem cells and chondrocytes)
alone or together with growth factors or PRP, and
. use systems with tunable degradation rates for
delivery of drugs and cells (drug concentration, cell
density, passage, and cell source should be evaluated).
The patient selection is also an important criterion in
future clinical trials to dictate the validity and efficacy of
the tissue engineering regenerative strategies for safe
translation in the daily clinical practice.
Conclusions
Our current knowledge on OA as a severe human dis-
order for which there is no reliable cure to date has
greatly increased from a basic point of view due to the
availability of a variety of clinically relevant animal
models, involving various, fine mechanisms that involve
all the tissues in the joint. The identification of the pro-
cesses and mediators underlying the initiation and pro-
gression of OA provides hope to establish adapted, novel
clinical treatments with a strong emphasis on the use of
MSCs and on tissue engineering approaches to deliver
effective and safe therapeutic compounds in patients in
a close future.
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